Melanoma/Skin Cancer News

FDA granted full approval to pembrolizumab for treatment of certain adults and children with unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors as determined through an FDA-approved test.

The FDA granted accelerated approval to retifanlimab-dlwr for treatment of adults with metastatic or recurrent locally advanced Merkel cell carcinoma.

The concept of cancer vaccination has generated excitement in the scientific community for decades.

Traditional histology typically guides treatment decisions for patients with colorectal cancer and various other malignancies, but it is unable to reveal a tumor’s molecular or structural features.

Although immunotherapies have been a game-changer in cancer treatment, they do not work for all patients.

Healio | HemOnc Today is excited to announce the nominees for its second annual Disruptive Innovators Awards in oncology and hematology.

The FDA announced several regulatory actions the past few weeks.

The economic cost of cancer worldwide from 2020 to 2050 will be $25.2 trillion in international dollars, according to results of a decision analytical modeling study published in JAMA Oncology.

Researchers observed significant racial disparities in all-cause and CVD mortality among adults with cancer, with wider gaps found among patients younger than 55 years, according to a study published in JACC: CardioOncology.

High BMI appeared associated with increased risk for any-grade immune-related adverse events among a cohort of patients with advanced cancer undergoing treatment with immune checkpoint inhibitors.